Biofrontera Inc. (BFRI)
NASDAQ: BFRI
· Real-Time Price · USD
0.92
-0.05 (-4.76%)
At close: Aug 15, 2025, 3:01 PM
Biofrontera Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.59M | -11.53M | -17.76M | -12.84M | -13.51M | -23.09M | -20.13M | -26.44M | -22.67M | -13.68M | -640K | -12.36M | -25.81M | -28.62M | -37.71M | -23.39M | -10.37M | -10.42M |
Depreciation & Amortization | 645K | 736K | 824K | 898K | 1.16M | 1.1M | 1.06M | 1.55M | 1.43M | 1.31M | 1.17M | 525K | 528K | 533K | 540K | 548K | 555K | 559K |
Stock-Based Compensation | 1.01M | 1.03M | 1.02M | 948K | 867K | 922K | 1.04M | 1.2M | 1.39M | 1.69M | 1.85M | 1.6M | 1.2M | 646K | 129K | n/a | n/a | n/a |
Other Working Capital | 6.79M | 6.08M | 5.63M | -7.3M | -11.33M | -10.92M | -8.34M | 1.72M | -1.66M | 5.23M | 5.67M | -6.85M | 6.31M | -130K | -3.41M | 10.82M | 92K | -619K |
Other Non-Cash Items | 8.3M | 1.1M | 5.54M | -7.98M | -14.82M | -9.3M | -11.44M | -160K | -3.78M | -10.97M | -21.37M | -21.9M | -17.79M | -10.18M | -977K | 2.02M | 1.81M | 2.29M |
Deferred Income Tax | n/a | n/a | n/a | 6.1M | 7.8M | 8.96M | 8.96M | 2.87M | 1.16M | n/a | n/a | 12.81M | 12.81M | 12.81M | 12.81M | n/a | n/a | n/a |
Change in Working Capital | -2.75M | -2.41M | 108K | -5.25M | -421K | -3.13M | -4.39M | -3.31M | -5.77M | 3.88M | 2.79M | -9.59M | 4.87M | -577K | -1.5M | 14.44M | 1.98M | -1.62M |
Operating Cash Flow | -9.39M | -11.06M | -10.27M | -18.12M | -18.91M | -24.53M | -24.89M | -24.3M | -28.24M | -17.78M | -16.2M | -28.92M | -24.19M | -25.38M | -26.71M | -6.39M | -6.02M | -9.19M |
Capital Expenditures | 45K | 44K | -10K | n/a | -50K | -48K | -5K | -15K | -16K | -47K | -38K | -46K | -44K | -16K | -11K | -2K | -3K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.12M | -5.12M | -5.12M | -5.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 57K | 121K | 503K | 681K | 624K | 560K | 178K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -50K | -50K | -50K | -50K | 178K | 178K | 3.21M | 178K | n/a | n/a | -3.04M | -11K | -11K | -11K | n/a | n/a | n/a |
Investing Cash Flow | -5K | -6K | -3K | 71K | 453K | 633K | 619K | -1.54M | -4.96M | -5.17M | -5.16M | -3.08M | -44K | -16K | -11K | -2K | -3K | n/a |
Debt Repayment | 3.04M | 884K | -979K | -2.46M | -1.22M | 2.04M | 3.9M | 1.7M | 1.11M | n/a | n/a | n/a | n/a | n/a | n/a | 3.29M | 3.29M | 7.49M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 16.88M | 8.38M | 8.38M | 357K | n/a | n/a | n/a | n/a | 4.63M | 14.02M | 14.02M | 57.85M | 53.1M | 43.19M | 43.19M | 406K | 1.34M | 4.4M |
Financial Cash Flow | 12.25M | 9.04M | 14.84M | 17.5M | 18.39M | 14.21M | 8.41M | -7.69M | -3.65M | 4.63M | 4.63M | 57.85M | 53.1M | 43.19M | 43.19M | 3.7M | 4.63M | 11.89M |
Net Cash Flow | 2.86M | -2.03M | 4.56M | -549K | -74K | -9.69M | -15.87M | -24.14M | -27.46M | -8.92M | -7.33M | 25.85M | 28.86M | 17.79M | 16.46M | -2.69M | -1.39M | 2.7M |
Free Cash Flow | -9.34M | -11.02M | -10.28M | -18.12M | -18.96M | -24.58M | -24.9M | -24.32M | -28.25M | -17.82M | -16.24M | -28.96M | -24.24M | -25.4M | -26.73M | -6.39M | -6.02M | -9.19M |